1354397-05-9

Upstream product

• 367-80-6 ethyl 4-fluoro-3-nitrobenzoate 
• 23821-99-0 4-chloro-2-methoxythiobenzamide 
• 89978-92-7 4-chloro-2-methoxybenzamide 
• 57479-70-6 2-methoxy-4-chlorobenzoic acid 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 27429-77-2 ethyl 1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-7-carboxylate 
• 71254-74-5 ethyl 3-amino-4-piperidin-1-ylbenzoate 
• 71254-72-3 ethyl 3-nitro-4-piperidin-1-ylbenzoate 
• 1354406-86-2 (1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-7-yl)methanol 
• 1354407-32-1 2-(4-chloro-2-methoxyphenyl)-4-methylthiazole-5-carboxylic acid 
• 1354407-29-6 ethyl 2-(4-chloro-2-methoxyphenyl)-4-methylthiazole-5-carboxylate 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR

A novel heterocyclic compound or a salt thereof useful for selectively inhibiting the degradation of p27Kip1 is provided. The compound or the salt thereof is represented by the following formula (1): wherein A represents an alkyl group, a cycloalkyl group, an aryl group or a heterocyclic group, the group A may have a substituent; the ring B represents a 5- to 8-membered monocyclic heterocyclic ring or a condensed ring containing the monocyclic heterocyclic ring, the ring B may have a substituent; the ring C represents an aromatic ring, the ring C may have a substituent; L represents a linker comprising a main chain having 3 to 5 atoms selected from the group consisting of a carbon atom, a nitrogen atom, an oxygen atom and a sulfur atom, wherein at least one atom in the main chain is a hetero atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, the linker L may have a substituent; and n is 0 or 1.